The product, CadalminTM Antihypercholesterolemic extract (CadalminTM ACe), is the only one “made by 100 per cent natural marine bioactive ingredients from seaweeds as a natural remedy of obesity and dyslipidemia,” according to Scientists at the Kochi headquartered Central Marine Fisheries Research Institute.
The product will be released by Governor P Sathasivam during the inaugural function of the Platinum Jubilee celebration of CMFRI on Saturday here, the institute said in a release. CMFRI scientists prepared the extract from seaweed which are commonly available in Indian coastal waters and are natural bounty of the sea and are known for their extraordinary medicinal properties, it said.
Dr Kajal Chakraborty, Senior Scientist in Marine Biotechnology Division of CMFRI, who developed the product, said bioactive pharmacophore leads from seaweeds were used to prepare the nutraceutical product.
“CadalminTM Antihypercholesterolemic extract can be administered to regulate clinical indicators leading to dyslipidemia or obesity, total adipose tissue and visceral fat, triglycerides, cholesterol, both good and bad, known as HDL and LDL,” Chakraborty said.
The product contains 100 per cent natural marine bioactive ingredients from selected seaweed by a patented technology, and would be made available in 400 mg capsules, the scientist said.